DK0565903T3 - Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter - Google Patents

Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter

Info

Publication number
DK0565903T3
DK0565903T3 DK93104573T DK93104573T DK0565903T3 DK 0565903 T3 DK0565903 T3 DK 0565903T3 DK 93104573 T DK93104573 T DK 93104573T DK 93104573 T DK93104573 T DK 93104573T DK 0565903 T3 DK0565903 T3 DK 0565903T3
Authority
DK
Denmark
Prior art keywords
analytes
specific
immunologically determining
binding partner
analyte
Prior art date
Application number
DK93104573T
Other languages
Danish (da)
English (en)
Inventor
Bernhard Auerbach
Helmut Peters
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0565903T3 publication Critical patent/DK0565903T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93104573T 1992-04-16 1993-03-19 Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter DK0565903T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4212706A DE4212706A1 (de) 1992-04-16 1992-04-16 Diagnostisches Verfahren zur immunologischen Bestimmung eines oder mehrerer Analyten

Publications (1)

Publication Number Publication Date
DK0565903T3 true DK0565903T3 (da) 1998-09-23

Family

ID=6456925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93104573T DK0565903T3 (da) 1992-04-16 1993-03-19 Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter

Country Status (9)

Country Link
US (1) US5593898A (es)
EP (1) EP0565903B1 (es)
JP (1) JP3308027B2 (es)
AT (1) ATE163229T1 (es)
AU (1) AU673822B2 (es)
CA (1) CA2094089A1 (es)
DE (2) DE4212706A1 (es)
DK (1) DK0565903T3 (es)
ES (1) ES2112348T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048301A2 (en) * 2001-10-11 2003-06-12 Protein Design Labs Inc. Anti-hla-dr antibodies and the methods of using thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836348A1 (de) * 1988-10-25 1990-04-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
DE4005630A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
EP0565903A2 (de) 1993-10-20
ATE163229T1 (de) 1998-02-15
JPH0666794A (ja) 1994-03-11
ES2112348T3 (es) 1998-04-01
EP0565903B1 (de) 1998-02-11
CA2094089A1 (en) 1993-10-17
JP3308027B2 (ja) 2002-07-29
DE59308129D1 (de) 1998-03-19
US5593898A (en) 1997-01-14
AU673822B2 (en) 1996-11-28
EP0565903A3 (es) 1994-01-05
DE4212706A1 (de) 1993-10-21
AU3692893A (en) 1993-10-21

Similar Documents

Publication Publication Date Title
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
DK165785A (da) Immunometrisk bestemmelse rettet mod flere steder
DK1016867T3 (da) Fremgangsmåde til immunassay af BNP
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
ES2064543T3 (es) Procedimiento para la determinacion de un analito.
DK0487301T3 (da) Fremgangsmåde til stabilisering af enzymkonjugater
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
DK603087A (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
ES2117067T3 (es) Procedimiento para la determinacion inmunoquimica de un analito.
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
DK0565903T3 (da) Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter
DE69310667D1 (de) Immunoassayverfahren unter Anwendung photothermischer Strahlablenkungsspektroskopie
ES2054686T3 (es) Equipo de inmunoensayo.
ES2126608T3 (es) Procedimiento para la determinacion de antigenos o anticuerpos en presencia de un inmunocomplejo.
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz
DE59610859D1 (de) Immunologische Bestimmungsmethode
DK249588D0 (da) Fremgangsmaade og middel til paavisning eller bestemmelse af en deltager i en partikelforstaerket immunologisk reaktion
DK582288D0 (da) Analysefremgangsmaade og saet til udfoerelse af fremgangsmaaden